Substance / Medication

Folic acid

Overview

Active Ingredient
folic acid
RxNorm CUI
4511

Indications

Dialyvite 3000 is a prescription folic acid supplement with additional nutrients indicated for use in improving the nutritional status of renal dialysis patients.

Labeler: Hillestad Pharmaceuticals USAUpdated: 2027-01-27T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

This product is contraindicated in patients with known hypersensitivity to any of the ingredients.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Folic acid supplementation during preconception period in sub-Saharan African countries: A systematic review and meta-analysis.
Aweke Mekuriaw Nibret, Fentie Elsa Awoke, Agimas Muluken Chanie et al. · PLoS One · 2025
PMID: 39888921Meta-AnalysisFull text (PMC)
Folic acid supplementation in European women of reproductive age and during pregnancy with excessive weight: a systematic review.
Loperfido Federica, Sottotetti Francesca, Bianco Irene et al. · Reprod Health · 2025
PMID: 39891165Meta-AnalysisFull text (PMC)
Consumption of folic acid fortified foods among Hispanic women of reproductive age in the US: a systematic review.
Villalba Nicole, Byrne Kayla, Abdelmageed Sunny et al. · BMC Public Health · 2025
PMID: 40205388Meta-AnalysisFull text (PMC)
Preconception Folic Acid and Multivitamin Supplementation for the Prevention of Neural Tube Defect: An Umbrella Review of Systematic Review and Meta-analysis.
Abate Biruk Beletew, Kumsa Henok, Kibret Gebremeskel Abebe et al. · Neuroepidemiology · 2025
PMID: 39074459Meta-Analysis
Impact of iron-folic acid supplementation on maternal and neonatal outcomes: A systematic review & meta-analysis.
Srivastava Manyata, Gulia Annu, Upadhyay Ashish Datt et al. · Nutr Health · 2025
PMID: 39569449Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Folic acid (substance)
SNOMED CT
63718003
UMLS CUI
C0016410
RxNorm CUI
4511
Labeler
Hillestad Pharmaceuticals USA

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.